11-30233638-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001382289.1(FSHB):​c.228C>T​(p.Tyr76Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.468 in 1,613,528 control chromosomes in the GnomAD database, including 182,686 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 22994 hom., cov: 32)
Exomes 𝑓: 0.46 ( 159692 hom. )

Consequence

FSHB
NM_001382289.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -1.40

Publications

28 publications found
Variant links:
Genes affected
FSHB (HGNC:3964): (follicle stimulating hormone subunit beta) The pituitary glycoprotein hormone family includes follicle-stimulating hormone, luteinizing hormone, chorionic gonadotropin, and thyroid-stimulating hormone. All of these glycoproteins consist of an identical alpha subunit and a hormone-specific beta subunit. This gene encodes the beta subunit of follicle-stimulating hormone. In conjunction with luteinizing hormone, follicle-stimulating hormone induces egg and sperm production. Alternative splicing results in two transcript variants encoding the same protein. [provided by RefSeq, Jul 2008]
ARL14EP-DT (HGNC:55517): (ARL14EP divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 11-30233638-C-T is Benign according to our data. Variant chr11-30233638-C-T is described in ClinVar as Benign. ClinVar VariationId is 257061.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.4 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.701 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FSHBNM_001382289.1 linkc.228C>T p.Tyr76Tyr synonymous_variant Exon 3 of 3 ENST00000533718.2 NP_001369218.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FSHBENST00000533718.2 linkc.228C>T p.Tyr76Tyr synonymous_variant Exon 3 of 3 1 NM_001382289.1 ENSP00000433424.1

Frequencies

GnomAD3 genomes
AF:
0.538
AC:
81711
AN:
151874
Hom.:
22969
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.708
Gnomad AMI
AF:
0.300
Gnomad AMR
AF:
0.541
Gnomad ASJ
AF:
0.466
Gnomad EAS
AF:
0.674
Gnomad SAS
AF:
0.579
Gnomad FIN
AF:
0.515
Gnomad MID
AF:
0.538
Gnomad NFE
AF:
0.432
Gnomad OTH
AF:
0.511
GnomAD2 exomes
AF:
0.512
AC:
128318
AN:
250780
AF XY:
0.509
show subpopulations
Gnomad AFR exome
AF:
0.712
Gnomad AMR exome
AF:
0.544
Gnomad ASJ exome
AF:
0.475
Gnomad EAS exome
AF:
0.670
Gnomad FIN exome
AF:
0.501
Gnomad NFE exome
AF:
0.438
Gnomad OTH exome
AF:
0.479
GnomAD4 exome
AF:
0.461
AC:
674149
AN:
1461534
Hom.:
159692
Cov.:
53
AF XY:
0.465
AC XY:
337836
AN XY:
727090
show subpopulations
African (AFR)
AF:
0.721
AC:
24139
AN:
33462
American (AMR)
AF:
0.544
AC:
24320
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.471
AC:
12304
AN:
26130
East Asian (EAS)
AF:
0.692
AC:
27436
AN:
39670
South Asian (SAS)
AF:
0.574
AC:
49515
AN:
86254
European-Finnish (FIN)
AF:
0.490
AC:
26180
AN:
53414
Middle Eastern (MID)
AF:
0.521
AC:
3001
AN:
5764
European-Non Finnish (NFE)
AF:
0.430
AC:
478349
AN:
1111762
Other (OTH)
AF:
0.479
AC:
28905
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
21529
43058
64586
86115
107644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14832
29664
44496
59328
74160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.538
AC:
81780
AN:
151994
Hom.:
22994
Cov.:
32
AF XY:
0.543
AC XY:
40347
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.708
AC:
29342
AN:
41464
American (AMR)
AF:
0.541
AC:
8266
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.466
AC:
1617
AN:
3472
East Asian (EAS)
AF:
0.675
AC:
3481
AN:
5160
South Asian (SAS)
AF:
0.578
AC:
2782
AN:
4812
European-Finnish (FIN)
AF:
0.515
AC:
5434
AN:
10560
Middle Eastern (MID)
AF:
0.537
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
0.432
AC:
29353
AN:
67942
Other (OTH)
AF:
0.509
AC:
1073
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1874
3747
5621
7494
9368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
698
1396
2094
2792
3490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.471
Hom.:
72688
Bravo
AF:
0.546
Asia WGS
AF:
0.582
AC:
2022
AN:
3476
EpiCase
AF:
0.444
EpiControl
AF:
0.436

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypogonadotropic hypogonadism 24 without anosmia Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.45
DANN
Benign
0.35
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6169; hg19: chr11-30255185; COSMIC: COSV54221663; API